Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT02938611
Recruiting Observational

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

NCT02938611 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Observational
Started
2019-01-01
Last updated
2025-03-10

Condition(s) studied

Renal Insufficiency, Chronic

Study summary

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * chronic kidney disease (stage \>= 4) Exclusion Criteria: \-

Primary outcome measure(s)

  • The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (raw number) — from baseline (day 0) to 12 months
  • The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (%) — from baseline (day 0) to 12 months

Trial sites (4)

FacilityCityRegionStatus
AIDER - Unité de Dialyse d'Alès Alès France Recruiting
AIDER - Unité de Dialyse de Nîmes, CHU Carémeau Nîmes France Not Yet Recruiting
CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes France Not Yet Recruiting
Gardialyse Nîmes France Not Yet Recruiting

More Centre Hospitalier Universitaire de Nīmes trials in France

Evaluation of Transthoracic Echocardiography Parameters and Their Changes in Blood Donor Volunteers Enrolling by invitation
Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being Starting soon
Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2 Recruiting
Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients with Cardio Renal Syndrome with Severe Renal Impairment Recruiting
Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical Prolapse in Women Recruiting

Other trials for the same condition

Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation. Recruiting
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) Recruiting
Living With Chronic Kidney Disease Without Renal Replacement Therapy: Experience of Women of Childbearing Age Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02938611 on ClinicalTrials.gov ↗ ← All trials in France